首页> 外文OA文献 >Growth of human gliomas in immune-deficient mice: a possible model for pre-clinical therapy studies.
【2h】

Growth of human gliomas in immune-deficient mice: a possible model for pre-clinical therapy studies.

机译:免疫缺陷小鼠中人神经胶质瘤的生长:临床前治疗研究的可能模型。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Thirteen gliomas from 55 neurosurgical specimens, derived from 25 adults and 30 children, have been successfully grown as subcutaneous xenografts in immune-deprived or nude mice. Only 2 of the 30 paediatric specimens implanted (6.7%), a medulloblastoma and an astrocytoma Grade III, have grown compared with 11 of the 25 adult specimen (44%) which were mostly astrocytomas Grade III. Tumour growth usually occurred several months after implantation, and karyotypic analysis confirmed their human origin in all cases. The histopathology of xenografted tumours correlated with the original surgical material, both after initial implantation and when tumours had been passaged several times. Observations on tumour growth in various types of immune-deprived mice indicated that, within certain limits, the immunological competence of the host mouse did not relate to take rates of primary implants, but could affect the take rate of passaged tumours.
机译:来自55个神经外科标本的13个神经胶质瘤来自25个成年人和30个儿童,已经在免疫不足或裸鼠中成功地作为皮下异种移植物生长。在植入的30个儿科标本中,只有2个(6.7%),髓母细胞瘤和3级星形细胞瘤已生长,而25个成人标本中的11个(44%)已生长,其中大部分是3级星形细胞瘤。肿瘤生长通常发生在植入后的几个月,并且核型分析证实了所有情况下的人类起源。异种移植肿瘤的组织病理学与最初的手术材料有关,无论是在最初植入后还是肿瘤经过数次传代时。对各种类型的免疫剥夺小鼠的肿瘤生长的观察表明,在一定限度内,宿主小鼠的免疫能力与原发植入物的摄取率无关,但可能影响传代肿瘤的摄取率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号